Moreover, molecular studies have shown that differentiated thyroid cancers (DTC) in Western Europe demonstrate a higher frequency of ras and GSP mutations than DTC cancers in American patients, suggesting that these mutations may play a more significant role in DTC cancers in Western Europe [39]. The gene discussed is GNAS; the disease is differentiated thyroid carcinoma.